Skip to main content
Bryan Cave Leighton Paisner LLP

Bryan Cave Leighton Paisner LLP

Bryan Cave and Berwin Leighton Paisner have combined to form Bryan Cave Leighton Paisner LLP. This account is not longer active but for all the latest news, updates and thought leadership follow our new page: BCLP.www.bryancave.com

Search complete. 7 mentions across 3 episodes found for "Bryan Cave Leighton Paisner LLP".

Sep 16, 2026

John GillenHOST
12:42
What was this merger of Sologentik and Quorium? What does that unlock? And give us some context for this.
Ashley EbersoleGUEST
12:47
When you said I was defending crypto companies that I was I first led the crypto practice at a law firm called Brian Cave for three years or so.
Ashley EbersoleGUEST
12:58
And then I went to 0x.
Ashley EbersoleGUEST
13:00
So I was defending more people at Brian Cave than at 0x.
Ashley EbersoleGUEST
13:05
You
John GillenHOST
13:06
were fighting the good fight in any capacity.
Lorena RuizNARRATOR
4:02
The EU AI Act classifies most medical AI as high risk, layering stringent requirements for data quality, documentation, and human oversight on top of existing device rules while US regulators and the Federal Trade Commission, FTC, tighten expectations on safety and reproductive data privacy.
Lorena RuizNARRATOR
4:22
European Commission, twenty twenty-five, Pinsent Masons, twenty twenty-five, BCLP, twenty twenty-four.
Lorena RuizNARRATOR
4:29
So what? In twenty twenty-six, viable AI and FemTech will be narrow, explainable, and clinician-anchored, embedded in workflows like Maven or BabyScripts rather than generic chatbots making unregulated diagnostic claims.
Lorena RuizNARRATOR
4:44
Jones Day, twenty twenty-five.
Lorena RuizNARRATOR
4:53
Investors, regulators, and retailers are converging on one demand: show outcomes.
Lorena RuizNARRATOR
4:59
CVS, Boots, and others stress evidence-based women's health offerings, and UK regulators have already acted against misleading menopause and fertility claims.
Lorena RuizNARRATOR
5:10
CVS Health, twenty twenty-four, BCLP, twenty twenty-four.
Lorena RuizNARRATOR
5:15
In the United States, the FDA's Tempo and Access pilots create faster paths for promising digital tools to be tested in real-world care while also locking in expectations for ongoing data collection and eventual full approval.
Alexis S. AxelradGUEST
44:44
You enjoy it and then you wonder the other shoe that's going to drop because we're winning.
Kevin A. GreggHOST
44:51
We are co-counsel with Brian Cave, Just Futures Law, and Raymond Audain in the Mayo TPS case.
Kevin A. GreggHOST
44:57
We, mostly Ira, heading the ship since 2018, beginning with the Sajay case.
Kevin A. GreggHOST
45:04
Mr. Sajay passed away and the HECA lawsuit as well.
Kevin A. GreggHOST
45:07
And then, of course, ACLU and other entities are involved with the Syrians.
Kevin A. GreggHOST
45:10
Our co-counsel at Brian Cave, Jeff Bufoli, argued before the Supreme Court with Ahilan.
Kevin A. GreggHOST
45:15
And, you know, we didn't know what was going to happen with Judge Reyes, whether she was going to grant the set aside before TPS was going to expire in February.
Kevin A. GreggHOST
45:27
And Jeff went to Springfield where they were eating cats and dogs.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.